Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up.

Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up.

BACKGROUND: The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) study showed that pravastatin therapy over 6 years reduced mortality and cardiovascular events in patients with previous acute coronary syndromes and average cholesterol concentrations. We assessed the longer-term...

Full description

Bibliographic Details
Main Author:	LIPID Study Group (Long-term Intervention with Pravastatin in Ischaemic Disease)
Format:	Journal article
Language:	English
Published:	2002

Similar Items

Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: is it cost-effective?
by: Glasziou, P, et al.
Published: (2002)

Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study.
by: Colquhoun, D, et al.
Published: (2004)

Detection of 4a,5-dihydropravastatin as Impurity in the Cholesterol Lowering Drug Pravastatin
by: Wibo B. van Scheppingen, et al.
Published: (2021-08-01)

Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: results from the LIPID study.
by: Tonkin, A, et al.
Published: (2006)

Lipid and apolipoprotein ratios: Association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin - Discussion
by: Stein, E, et al.
Published: (2003)

Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease.
by: Reid, I, et al.
Published: (2001)

Guidelines for lowering lipids to reduce coronary artery disease risk: A comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals - Discussion
by: Davidson, M, et al.
Published: (2003)

Treatment of familial hypercholesterolaemia. United Kingdom lipid clinics study of pravastatin and cholestyramine.
by: Betteridge, D, et al.
Published: (1992)

Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study.
by: Tonkin, A, et al.
Published: (2000)

Pravastatin therapy and the risk of stroke.
by: White, H, et al.
Published: (2000)

Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations.
by: Chen, Z, et al.
Published: (1991)

Relationship between Dietary Habits and Control of Lipid Profiles in Patients with Dyslipidemia Using Pravastatin
by: Seo Young Kang, et al.
Published: (2021-10-01)

Long-term risk stratification for survivors of acute coronary syndromes. Results from the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study. LIPID Study Investigators.
by: Marschner, I, et al.
Published: (2001)

The possibility of using pravastatin in plant protection
by: Kartashov M.I.
Published: (2014-12-01)

Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial
by: Reid, I, et al.
Published: (2001)

Effect of Pravastatin and Simvastatin on the Reduction of Cytochrome C
by: Krisztián Csomó, et al.
Published: (2022-07-01)

Expert consensus on clinical pathway of blood lipid management in patients with acute coronary syndrome
by: Chinese Medical Doctor Association, Expert Group of Clinical Pathway of Lipid Management in Patients with Acute Coronary Syndrome
Published: (2020-01-01)

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.
by: Sever, P, et al.
Published: (2004)

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.
by: Sever, P, et al.
Published: (2003)

Lipid screening: is it enough to measure total cholesterol concentration?
by: Neil, H, et al.
Published: (1990)

Production of Pravastatin by Filamentous Fungi Isolated from Soil
by: Emine, Seydametova
Published: (2013)

Pravastatin in preeclampsia: A meta-analysis and systematic review
by: Balázs Mészáros, et al.
Published: (2023-01-01)

Correction to: Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes
by: Mario Luca Morieri, et al.
Published: (2022-05-01)

Cholesterol and lipids
by: Baigent, C, et al.
Published: (2008)

Formulation Development and Evaluation of Pravastatin-Loaded Nanogel for Hyperlipidemia Management
by: Gaurav Kant Saraogi, et al.
Published: (2022-01-01)

Characterization of Human Erythrocytes as Potential Carrier for Pravastatin: An In Vitro Study
by: Gamal El-din I. Harisa, Mohamed F. Ibrahim, Fars K. Alanazi
Published: (2011-01-01)

Pravastatin Modulate Niemann-Pick C1-Like 1 and ATP-Binding Cassette G5 and G8 to Influence Intestinal Cholesterol Absorption
by: Atsushi Kawase, et al.
Published: (2015-11-01)

Comparison of fat intake in Australian and New Zealand CHD patients: The LIPID (long term intervention with Pravastatin in ischaemic disease) study
by: Nestel, P, et al.
Published: (2002)

Pravastatin normalises peripheral cardiac sympathetic hyperactivity in the spontaneously hypertensive rat
by: Herring, N, et al.
Published: (2010)

Pravastatin normalises peripheral cardiac sympathetic hyperactivity in the spontaneously hypertensive rat.
by: Herring, N, et al.
Published: (2011)

Novel Pravastatin-Producing Penicillium janthinellum Strain Isolated from Soil
by: Seydametova, Emine
Published: (2015)

The Effects of Prenatal Pravastatin Treatment in the Rabbit Fetal Growth Restriction Model
by: Katerina Zapletalova, et al.
Published: (2023-09-01)

Pravastatin Administration Alleviates Kanamycin-Induced Cochlear Injury and Hearing Loss
by: Chang Ho Lee, et al.
Published: (2022-04-01)

Neuroprotective effects of pravastatin in cerebral venous infarction in a rat model
by: Fumiya Sato, et al.
Published: (2023-06-01)

Lichenoid drug eruption induced by pravastatin; it is possible to prescribe other statins?
by: Francisco J. Navarro-Triviño, et al.
Published: (2023-04-01)

Mood Stabilizer Therapy and Pravastatin: Higher Risk for Adverse Skin Reactions?
by: Alice Walder, et al.
Published: (2009-01-01)

Relationship between low-density lipoprotein cholesterol, lipid-lowering agents and risk of stroke: a meta-analysis of observational studies (n = 355,591) and randomized controlled trials (n = 165,988)
by: Maciej Banach, et al.
Published: (2022-01-01)

Coronary Artery Disease with Elevated Levels of HDL Cholesterol Is Associated with Distinct Lipid Signatures
by: Wanying Xia, et al.
Published: (2023-05-01)

Concentration of lipids, cholesterol, and fatty acid profile in chicken breast meat affected by wooden breast myopathy frozen for up to 12 mo
by: Erick Alonso Villegas-Cayllahua, et al.
Published: (2024-01-01)

From Dietary Cholesterol to Blood Cholesterol, Physiological Lipid Fluxes, and Cholesterol Homeostasis
by: Frans Stellaard
Published: (2022-04-01)